Trial Profile
Effect of Endoplasmic Reticulum Stress on Metabolic Function.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Sodium phenylbutyrate (Primary) ; Ursodoxicoltaurine (Primary)
- Indications Obesity
- Focus Therapeutic Use
- Acronyms TUDCA/PBA
- 29 Apr 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 09 Dec 2013 Planned end Ddte changed from 1 Sep 2011 to 1 Dec 2014 as reported by ClinicalTrials.gov.
- 09 Dec 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.